Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (EIV) in horses

Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (EIV) in horses

US Patent 11576963 · Granted Feb 14, 2023

Estimated economic value: $2,224,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-influenza neuraminidase monoclonal antibodies and uses thereof2025
Multivalent live-attenuated influenza vaccine for prevention and control of equi2025
Multivalent live-attenuated influenza vaccine for prevention and control of equi2025
Anti-influenza neuraminidase monoclonal antibodies and uses thereof2024
Broadly neutralizing anti-influenza human monoclonal antibody and uses thereof2021
Live-attenuated vaccine having mutations in viral polymerase for the treatment a2021
NS1 truncated virus for the development of canine influenza vaccines2021
Equine influenza virus live attenuated vaccines2020
Single-cycle virus for the development of canine influenza vaccines2020
Live-attenuated vaccine having mutations in viral polymerase for the treatment a2019
Arenavirus vaccine2019
Methods and compositions related to reorganization of arenavirus genome for deve2018